News Study upholds use of metformin monotherapy for first-line diabetes treatment Patients recently diagnosed with diabetes who are prescribed metformin monotherapy are less likely to require treatment intensification compared with patients prescribed other oral glucose-lowering medications as a monotherapy.…Published: 10 November 2014
News Diabetic wounds heal faster with deferoxamine patch Researchers have developed a transdermal patch that delivers the small molecule deferoxamine to accelerate wound healing in diabetes.…Published: 3 November 2014
News Mortality risk should be considered with choice of sulfonylurea drug Some sulfonylurea drugs, such as gliclazide and glimepiride, are associated with a lower mortality risk than others.…Published: 3 November 2014
News Diabetes patients could be quizzed about driving habits during medication reviewsPeople with diabetes could be questioned about their driving habits as part of their medication review, under proposals contained in a report by the Transport Research Laboratory. …Published: 30 October 2014
Opinion My first rotationAt the end of her rotation covering diabetes wards, Sadia Naeem reflects on what she learnt from the experience.…Published: 20 October 2014
News Diabetes drug is activated by light to cause pancreas to release insulin Scientists have developed a “photoswitchable” version of the diabetes drug glimepiride that is activated through exposure to blue light, allowing insulin release by pancreatic cells to be optically controlled.…Published: 17 October 2014
News Scientists develop human insulin-producing cells to treat type 1 diabetes In a step towards developing a cell therapy for type 1 diabetes, stem cell researchers at Harvard University have sucessully implanted human insulin-producing cells.…Published: 14 October 2014
News New pharmacological approach could treat type 2 diabetes Anthelmintic drug niclosamide could provide a potentially new pharmacological approach for treating type 2 diabetes.…Published: 10 October 2014
News Long-acting insulin ‘probably superior’ to intermediate-acting insulin New research favours long-acting insulin over intermediate-acting versions due to the greater reduction in haemoglobin A1c, less weight gain and lower incidence of severe hypoglycaemia.…Published: 7 October 2014
News Statin target linked to increased risk of diabetes and weight gain Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase is partly responsible for the increased risk of type 2 diabetes seen with statin treatment.…Published: 1 October 2014
